The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oxymorphone Hydrochloride Market Research Report 2025
Synopsis
It is a highly potent opioid analgesic indicated for treatment of severe pain
Global Oxymorphone Hydrochloride market is projected to reach US$ 4067.7 million in 2029, increasing from US$ 1840 million in 2022, with the CAGR of 12.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oxymorphone Hydrochloride market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oxymorphone Hydrochloride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Teva
Ajanta Pharma
Aurobindo Pharma
Avanthi Pharma
Endo Pharm
Epic Pharma
Hikma Pharmaceuticals
Amneal Pharmaceutical
Mallinckrodt Pharmaceuticals
Par Pharmaceutical
Sun Pharmaceutical
Humanwell
Aurolife Pharma LLC
Segment by Type
30Mg
10Mg
5Mg
Other
Segment by Application
Chronic Lymphocytic Leukemia
Follicular Lymphoma
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oxymorphone Hydrochloride report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
It is a highly potent opioid analgesic indicated for treatment of severe pain
Global Oxymorphone Hydrochloride market is projected to reach US$ 4067.7 million in 2029, increasing from US$ 1840 million in 2022, with the CAGR of 12.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oxymorphone Hydrochloride market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oxymorphone Hydrochloride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Teva
Ajanta Pharma
Aurobindo Pharma
Avanthi Pharma
Endo Pharm
Epic Pharma
Hikma Pharmaceuticals
Amneal Pharmaceutical
Mallinckrodt Pharmaceuticals
Par Pharmaceutical
Sun Pharmaceutical
Humanwell
Aurolife Pharma LLC
Segment by Type
30Mg
10Mg
5Mg
Other
Segment by Application
Chronic Lymphocytic Leukemia
Follicular Lymphoma
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oxymorphone Hydrochloride report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Oxymorphone Hydrochloride Market Overview
1.1 Product Overview and Scope of Oxymorphone Hydrochloride
1.2 Oxymorphone Hydrochloride Segment by Type
1.2.1 Global Oxymorphone Hydrochloride Market Value Comparison by Type (2023-2029)
1.2.2 30Mg
1.2.3 10Mg
1.2.4 5Mg
1.2.5 Other
1.3 Oxymorphone Hydrochloride Segment by Application
1.3.1 Global Oxymorphone Hydrochloride Market Value by Application: (2023-2029)
1.3.2 Chronic Lymphocytic Leukemia
1.3.3 Follicular Lymphoma
1.4 Global Oxymorphone Hydrochloride Market Size Estimates and Forecasts
1.4.1 Global Oxymorphone Hydrochloride Revenue 2018-2029
1.4.2 Global Oxymorphone Hydrochloride Sales 2018-2029
1.4.3 Global Oxymorphone Hydrochloride Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oxymorphone Hydrochloride Market Competition by Manufacturers
2.1 Global Oxymorphone Hydrochloride Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oxymorphone Hydrochloride Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oxymorphone Hydrochloride Average Price by Manufacturers (2018-2023)
2.4 Global Oxymorphone Hydrochloride Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oxymorphone Hydrochloride, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oxymorphone Hydrochloride, Product Type & Application
2.7 Oxymorphone Hydrochloride Market Competitive Situation and Trends
2.7.1 Oxymorphone Hydrochloride Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oxymorphone Hydrochloride Players Market Share by Revenue
2.7.3 Global Oxymorphone Hydrochloride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oxymorphone Hydrochloride Retrospective Market Scenario by Region
3.1 Global Oxymorphone Hydrochloride Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oxymorphone Hydrochloride Global Oxymorphone Hydrochloride Sales by Region: 2018-2029
3.2.1 Global Oxymorphone Hydrochloride Sales by Region: 2018-2023
3.2.2 Global Oxymorphone Hydrochloride Sales by Region: 2024-2029
3.3 Global Oxymorphone Hydrochloride Global Oxymorphone Hydrochloride Revenue by Region: 2018-2029
3.3.1 Global Oxymorphone Hydrochloride Revenue by Region: 2018-2023
3.3.2 Global Oxymorphone Hydrochloride Revenue by Region: 2024-2029
3.4 North America Oxymorphone Hydrochloride Market Facts & Figures by Country
3.4.1 North America Oxymorphone Hydrochloride Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oxymorphone Hydrochloride Sales by Country (2018-2029)
3.4.3 North America Oxymorphone Hydrochloride Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oxymorphone Hydrochloride Market Facts & Figures by Country
3.5.1 Europe Oxymorphone Hydrochloride Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oxymorphone Hydrochloride Sales by Country (2018-2029)
3.5.3 Europe Oxymorphone Hydrochloride Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oxymorphone Hydrochloride Market Facts & Figures by Country
3.6.1 Asia Pacific Oxymorphone Hydrochloride Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oxymorphone Hydrochloride Sales by Country (2018-2029)
3.6.3 Asia Pacific Oxymorphone Hydrochloride Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oxymorphone Hydrochloride Market Facts & Figures by Country
3.7.1 Latin America Oxymorphone Hydrochloride Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oxymorphone Hydrochloride Sales by Country (2018-2029)
3.7.3 Latin America Oxymorphone Hydrochloride Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oxymorphone Hydrochloride Market Facts & Figures by Country
3.8.1 Middle East and Africa Oxymorphone Hydrochloride Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oxymorphone Hydrochloride Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oxymorphone Hydrochloride Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oxymorphone Hydrochloride Sales by Type (2018-2029)
4.1.1 Global Oxymorphone Hydrochloride Sales by Type (2018-2023)
4.1.2 Global Oxymorphone Hydrochloride Sales by Type (2024-2029)
4.1.3 Global Oxymorphone Hydrochloride Sales Market Share by Type (2018-2029)
4.2 Global Oxymorphone Hydrochloride Revenue by Type (2018-2029)
4.2.1 Global Oxymorphone Hydrochloride Revenue by Type (2018-2023)
4.2.2 Global Oxymorphone Hydrochloride Revenue by Type (2024-2029)
4.2.3 Global Oxymorphone Hydrochloride Revenue Market Share by Type (2018-2029)
4.3 Global Oxymorphone Hydrochloride Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oxymorphone Hydrochloride Sales by Application (2018-2029)
5.1.1 Global Oxymorphone Hydrochloride Sales by Application (2018-2023)
5.1.2 Global Oxymorphone Hydrochloride Sales by Application (2024-2029)
5.1.3 Global Oxymorphone Hydrochloride Sales Market Share by Application (2018-2029)
5.2 Global Oxymorphone Hydrochloride Revenue by Application (2018-2029)
5.2.1 Global Oxymorphone Hydrochloride Revenue by Application (2018-2023)
5.2.2 Global Oxymorphone Hydrochloride Revenue by Application (2024-2029)
5.2.3 Global Oxymorphone Hydrochloride Revenue Market Share by Application (2018-2029)
5.3 Global Oxymorphone Hydrochloride Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Oxymorphone Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Teva Oxymorphone Hydrochloride Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Ajanta Pharma
6.2.1 Ajanta Pharma Corporation Information
6.2.2 Ajanta Pharma Description and Business Overview
6.2.3 Ajanta Pharma Oxymorphone Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Ajanta Pharma Oxymorphone Hydrochloride Product Portfolio
6.2.5 Ajanta Pharma Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Corporation Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Oxymorphone Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Aurobindo Pharma Oxymorphone Hydrochloride Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 Avanthi Pharma
6.4.1 Avanthi Pharma Corporation Information
6.4.2 Avanthi Pharma Description and Business Overview
6.4.3 Avanthi Pharma Oxymorphone Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Avanthi Pharma Oxymorphone Hydrochloride Product Portfolio
6.4.5 Avanthi Pharma Recent Developments/Updates
6.5 Endo Pharm
6.5.1 Endo Pharm Corporation Information
6.5.2 Endo Pharm Description and Business Overview
6.5.3 Endo Pharm Oxymorphone Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Endo Pharm Oxymorphone Hydrochloride Product Portfolio
6.5.5 Endo Pharm Recent Developments/Updates
6.6 Epic Pharma
6.6.1 Epic Pharma Corporation Information
6.6.2 Epic Pharma Description and Business Overview
6.6.3 Epic Pharma Oxymorphone Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Epic Pharma Oxymorphone Hydrochloride Product Portfolio
6.6.5 Epic Pharma Recent Developments/Updates
6.7 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Corporation Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Oxymorphone Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hikma Pharmaceuticals Oxymorphone Hydrochloride Product Portfolio
6.7.5 Hikma Pharmaceuticals Recent Developments/Updates
6.8 Amneal Pharmaceutical
6.8.1 Amneal Pharmaceutical Corporation Information
6.8.2 Amneal Pharmaceutical Description and Business Overview
6.8.3 Amneal Pharmaceutical Oxymorphone Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Amneal Pharmaceutical Oxymorphone Hydrochloride Product Portfolio
6.8.5 Amneal Pharmaceutical Recent Developments/Updates
6.9 Mallinckrodt Pharmaceuticals
6.9.1 Mallinckrodt Pharmaceuticals Corporation Information
6.9.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.9.3 Mallinckrodt Pharmaceuticals Oxymorphone Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Mallinckrodt Pharmaceuticals Oxymorphone Hydrochloride Product Portfolio
6.9.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.10 Par Pharmaceutical
6.10.1 Par Pharmaceutical Corporation Information
6.10.2 Par Pharmaceutical Description and Business Overview
6.10.3 Par Pharmaceutical Oxymorphone Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Par Pharmaceutical Oxymorphone Hydrochloride Product Portfolio
6.10.5 Par Pharmaceutical Recent Developments/Updates
6.11 Sun Pharmaceutical
6.11.1 Sun Pharmaceutical Corporation Information
6.11.2 Sun Pharmaceutical Oxymorphone Hydrochloride Description and Business Overview
6.11.3 Sun Pharmaceutical Oxymorphone Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sun Pharmaceutical Oxymorphone Hydrochloride Product Portfolio
6.11.5 Sun Pharmaceutical Recent Developments/Updates
6.12 Humanwell
6.12.1 Humanwell Corporation Information
6.12.2 Humanwell Oxymorphone Hydrochloride Description and Business Overview
6.12.3 Humanwell Oxymorphone Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Humanwell Oxymorphone Hydrochloride Product Portfolio
6.12.5 Humanwell Recent Developments/Updates
6.13 Aurolife Pharma LLC
6.13.1 Aurolife Pharma LLC Corporation Information
6.13.2 Aurolife Pharma LLC Oxymorphone Hydrochloride Description and Business Overview
6.13.3 Aurolife Pharma LLC Oxymorphone Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Aurolife Pharma LLC Oxymorphone Hydrochloride Product Portfolio
6.13.5 Aurolife Pharma LLC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oxymorphone Hydrochloride Industry Chain Analysis
7.2 Oxymorphone Hydrochloride Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oxymorphone Hydrochloride Production Mode & Process
7.4 Oxymorphone Hydrochloride Sales and Marketing
7.4.1 Oxymorphone Hydrochloride Sales Channels
7.4.2 Oxymorphone Hydrochloride Distributors
7.5 Oxymorphone Hydrochloride Customers
8 Oxymorphone Hydrochloride Market Dynamics
8.1 Oxymorphone Hydrochloride Industry Trends
8.2 Oxymorphone Hydrochloride Market Drivers
8.3 Oxymorphone Hydrochloride Market Challenges
8.4 Oxymorphone Hydrochloride Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
